nach oben

Erschienen in:

01.05.2023 | News item

Mercaptopurine-related risk of macrophage activation syndrome

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

The Serious Warnings and Precautions Box, Warnings and Precautions, Adverse Reactions, and Patient Medication Information sections of the Canadian product monograph for Purinethol (mercaptopurine) have been updated with the risk of macrophage activation syndrome (MAS), advises Health Canada in Health Product Infowatch . …

Product monograph updates - Purinethol (mercaptopurine) Health Product InfoWatch : 27 Apr 2023. Available from: URL: https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada/health-product-infowatch/april-2023.html#a5.1.2

Titel: Mercaptopurine-related risk of macrophage activation syndrome
Publikationsdatum: 01.05.2023
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-38618-2

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Mercaptopurine-related risk of macrophage activation syndrome

Excerpt

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2023

Dabigatran-etexilate

Potassium/tacrolimus/trimethoprim

Cotrimoxazole

Tozinameran

Pembrolizumab

Ranibizumab